DalsnaFinance › IPOs › TRex Bio › IPO
TRex Bio, Inc. completed its initial public offering on Nasdaq on October 6, 2026, pricing at $14.00 a share.
| Ticker | TRXB |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | October 6, 2026 |
| Offering price | $14.00 |
| Sector | Biological Products, (No Diagnostic Substances) |
TRex Bio, Inc. listed on Nasdaq on 2026-10-06.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2139097.
TRex Bio, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for TRex Bio, Inc.. This page is general information, not investment advice.